Trump Unveils Deal With Regeneron To Lower Drug Prices

President Donald Trump has announced a deal with Regeneron to lower the cost of its pharmaceutical products. The agreement, announced Thursday, includes lowering the prices of current and future drugs on Medicaid and selling a cholesterol drug for $225 on the White House’s discounted drug website, TrumpRx. The deal first reported by NOTUS is part of the Trump administration's efforts to provide economic relief to Americans ahead of the midterm elections. It's one of many deals the White House has struck that aim to align U.S. pharmaceutical prices with other developed nations. Details of these agreements remain undisclosed, but Health Secretary Robert F. Kennedy Jr. says nonproprietary information will be shared with Congress.